Accéder au contenu
Merck

Chlorambucil drug resistance in chronic lymphocytic leukemia: the emerging role of DNA repair.

Clinical cancer research : an official journal of the American Association for Cancer Research (2001-04-12)
L Panasci, J P Paiement, G Christodoulopoulos, A Belenkov, A Malapetsa, R Aloyz
RÉSUMÉ

Various mechanisms have been implicated in nitrogen mustard drug resistance. The role of these mechanisms in the development of chlorambucil drug resistance in chronic lymphocytic leukemia (CLL) is discussed. We review these mechanisms with emphasis on the emerging role of DNA repair, and specifically, recombinational repair. Inhibition of these repair processes may lead to new therapies, not only in CLL, but in other malignancies as well.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
Chlorambucil
Chlorambucil, European Pharmacopoeia (EP) Reference Standard
Chlorambucil for system suitability, European Pharmacopoeia (EP) Reference Standard